tiprankstipranks
Curative Biotechnology (CUBT)
OTHER OTC:CUBT
US Market
Holding CUBT?
Track your performance easily

Curative Biotechnology (CUBT) Financial Statements

15 Followers

Curative Biotechnology Financial Overview

Curative Biotechnology's market cap is currently ―. The company's EPS TTM is $-0.007; its P/E ratio is -1.83; Curative Biotechnology is scheduled to report earnings on May 25, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBIT$ -1.08M$ -963.38K$ -1.29M$ -935.94K$ -1.02M
EBITDA$ -1.07M$ -961.39K$ -1.29M$ -933.95K$ -1.01M
Net Income Common Stockholders$ -1.42M$ -1.29M$ -1.40M$ -935.94K$ -1.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 636.00$ 126.85K$ 310.23K$ 670.26K-
Total Assets$ 2.01M$ 2.03M$ 2.20M$ 2.41M-
Total Debt$ 846.55K$ 580.95K$ 155.93K$ 0.00$ 0.00
Net Debt$ 845.91K$ 454.10K$ -154.30K$ -670.26K$ 0.00
Total Liabilities$ 21.13M$ 20.01M$ 18.89M$ 18.77M-
Stockholders Equity$ -19.12M$ -17.98M$ -16.69M$ -16.36M-
Cash Flow-
Free Cash Flow$ -211.26K$ -315.05K$ -1.22M$ -586.61K$ -421.28K
Operating Cash Flow$ -174.99K$ -310.69K$ -1.19M$ -579.77K$ -415.28K
Investing Cash Flow$ -36.27K$ -4.36K$ -36.27K$ -6.83K$ -6.00K
Financing Cash Flow$ 85.05K$ 131.67K$ 861.94K$ 525.02K$ 425.00K
Currency in USD

Curative Biotechnology Earnings and Revenue History

Curative Biotechnology Debt to Assets

Curative Biotechnology Cash Flow

Curative Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis